Fredric Cohen
No más puestos en curso
Perfil
Fredric Cohen worked as an Executive Director-Clinical Pipeline at Aptalis Pharma, Inc. from 2009 to 2014.
He was also a Principal at Crownstone Group from 2003 to 2006.
Cohen worked as a Senior VP-Global Research & Development at Strongbridge Biopharma Plc in 2016.
He was a Principal at Eli Lilly & Co. Cohen received his undergraduate degree from Franklin & Marshall College and his doctorate from Pennsylvania State University College of Medicine.
Antiguos cargos conocidos de Fredric Cohen.
| Empresas | Cargo | Fin |
|---|---|---|
Aptalis Pharma LLC
 Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Corporate Officer/Principal | 01/03/2014 |
| Crownstone Group | Director de Investigación - Acciones | 30/03/2006 |
| STRONGBRIDGE BIOPHARMA | Director Técnico/Científico/I+D | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formación de Fredric Cohen.
| Franklin & Marshall College | Undergraduate Degree |
| Pennsylvania State University College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Empresas privadas | 3 |
|---|---|
Aptalis Pharma LLC
Aptalis Pharma LLC Pharmaceuticals: MajorHealth Technology Aptalis Pharma, Inc. develops, manufactures, markets pharmaceutical products for cystic fibrosis and gastroenterology. The company's products include Zenpep, Canasa, Carafate, Pylera, Lacteal, Panzytrat, Delursan, Rectiv and Salofalk.. It provides therapies for unmet medical needs including cystic fibrosis and gastrointestinal disorders. The company formulates and clinically develops enhanced pharmaceutical and biopharmaceutical products for itself and others using its proprietary pharmaceutical technology. Aptalis Pharma was founded 1982 and is headquartered in Birmingham, AL. | Health Technology |
| Crownstone Group | Finance |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Fredric Cohen
